SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-17-003805
Filing Date
2017-04-28
Accepted
2017-04-28 17:01:14
Documents
5
Period of Report
2017-06-14
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT tenx_def14a.htm DEF 14A 873198
2 IMAGE detach.jpg GRAPHIC 5279
3 IMAGE internet.jpg GRAPHIC 8113
4 IMAGE mail.jpg GRAPHIC 8542
5 IMAGE phone.jpg GRAPHIC 8848
  Complete submission text file 0001654954-17-003805.txt   901311
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34600 | Film No.: 17796746
SIC: 8731 Services-Commercial Physical & Biological Research